logo
ResearchBunny Logo
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Medicine and Health

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

T. Li, W. Xue, et al.

This groundbreaking study uncovers two powerful cross-neutralizing antibodies, 7D6 and 6D6, targeting the conserved Sarbecovirus receptor-binding domain, providing promising avenues for therapeutic and vaccine development against diverse SARS-CoV-2 variants. Conducted by a team of expert researchers, including Tingting Li and Wenhui Xue, this work is a leap forward in the fight against COVID-19.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny